A Creatinine That Rose After Starting a New Medicine
For the medicines most often blamed for this, the rise is the intended effect showing up in the blood, and guidelines say plainly not to stop the drug for it. NICE advises against stopping a renin-angiotensin system antagonist when the eGFR has fallen by less than 25% or the creatinine has risen by less than 30% from where it started. Stopping a kidney-protecting drug because of the number that proves it is working is a common and costly mistake.
The pattern on your report
- Creatinine High · mild Key
- eGFR Low Key
- Potassium High-normal Key
- Urea High-normal Key
Printed as: Urea in mmol/Lor mg/dL— Reported as BUN in conventional units. Unmoved when a drug is merely blocking creatinine's exit.Creatinine in umol/Lor mg/dL— Judged as a proportional change from your own pre-treatment value, not against the printed range.eGFR in mL/min/1.73m2Potassium in mmol/Lor mEq/L— The same figure under two names. This is the number that can require urgent action with these drugs.
Why the numbers look like this
The kidney filters blood under pressure generated across each tiny filtering unit, controlled by two small arteries: one delivering blood and one draining it. ACE inhibitors and angiotensin receptor blockers relax the draining artery, which lowers the pressure across the filter.
Lower pressure means slightly less filtration, so the creatinine rises. It also means the filter is doing less work under strain, and it is precisely that reduction in strain that slows the long-term damage these drugs are prescribed to prevent. The short-term number and the long-term benefit come from the same mechanism, pointing in opposite directions.
SGLT2 inhibitors produce a similar early dip through a different route, and the same logic applies: the initial fall is followed by slower decline over years.
A second group of drugs does something entirely different. Trimethoprim and cimetidine block the tubule from secreting creatinine into the urine. Filtration is unchanged, but less creatinine leaves, so the level rises. Nothing has happened to the kidney at all.
Not being flagged is not the same as normal
The comparison that matters is against your own pre-treatment value, not against the printed range, and that makes a baseline taken before starting the drug more useful than any single result afterwards. Both figures quoted above are proportional changes from that baseline. Timing matters too: the effect shows up within the first week or two after starting or after a dose goes up, so the check is arranged then and not months later.
What else on the report can hide this
Potassium is checked alongside, and not because of anything to do with the creatinine. The same drugs raise it, and a high potassium is the change that genuinely requires action, sometimes urgently.
Urea read next to creatinine helps distinguish the mechanisms. A drug blocking creatinine secretion leaves urea untouched, so a creatinine that has moved alone points there. Reduced filtration moves both.
What else changed at the same time is worth reconstructing carefully. Starting a diuretic, a bout of vomiting or diarrhea, or a spell of hot weather all reduce circulating volume, and any of them combined with these drugs produces a much larger rise than the drug alone would.
Anti-inflammatories deserve a specific question. Taken with an ACE inhibitor and a diuretic, they form a combination well known for causing acute kidney injury, and people rarely mention them because they were bought rather than prescribed.
If the rise is larger than the thresholds allow, the response is not simply to stop and move on. It is a reason to look for narrowed kidney arteries, volume depletion or an interacting drug, because a disproportionate response points at something worth finding.
What usually causes it
Listed from most to least common — not from most to least serious.
- Very common
An ACE inhibitor or angiotensin receptor blocker
An expected, mechanism-driven rise appearing in the first weeks. Within the thresholds above it is a reason to continue, not to stop.
- Very common
An SGLT2 inhibitor
A small early dip in filtration followed by slower long-term decline. The dip is anticipated and the drug is continued through it.
- Common
Trimethoprim or cimetidine
Blocks creatinine's exit into the urine without changing filtration. Urea stays put, and the level returns to baseline on stopping.
- Common
A diuretic started at the same time
Volume depletion amplifies the effect substantially. The combination explains rises far larger than either drug alone would produce.
- Common
A non-steroidal anti-inflammatory
Constricts the delivering artery while the other drug relaxes the draining one. Frequently bought over the counter and not mentioned.
- Common
Dehydration from illness or heat
From the history. Vomiting, diarrhea or hot weather turn a tolerated drug into a problem, which is why sick-day guidance exists.
- Uncommon
Narrowing of the kidney arteries
Produces a disproportionate rise, well beyond the expected range. Suspected when the response is much larger than the dose should cause.
- Uncommon
Calcineurin inhibitors — in people who have had a transplant
Reduce filtration in a dose-dependent way, so drug levels rather than the creatinine alone guide the adjustment.
- Rare
Acute interstitial nephritis
An allergic reaction in the kidney, often to an antibiotic or a proton pump inhibitor. Sometimes with rash, fever or eosinophils, and it needs the drug stopped.
What is usually checked next
- Compare against the pre-treatment baseline The thresholds are proportional changes from your own starting point, so a value without a baseline cannot be judged.
- Potassium The change that actually requires action with these drugs, and it can need it urgently.
- Urea alongside creatinine A creatinine that has risen alone points to blocked secretion; both rising points to reduced filtration.
- A review of everything else that changed, including bought medicines Anti-inflammatories and new diuretics account for most of the rises that exceed the expected range.
- Investigation for renal artery narrowing if the rise is disproportionate An outsized response is a pointer rather than a reason to stop and forget the drug.
When to seek care sooner
- Emergency Passing little or no urine
- Emergency Palpitations, muscle weakness, or a high potassium result
- Same day Breathlessness with swelling of the legs
- Same day A creatinine rise well beyond what the medicine explains
- Soon Vomiting or diarrhea while taking these medicines
- Soon A new rash with fever after starting a medicine
Questions worth bringing to your appointment
- What was my creatinine before I started this medicine?
- How large is the change in percentage terms?
- Does this fall within the range where the medicine should be continued?
- Has my potassium been checked?
- What should I do about this medicine if I get vomiting or diarrhea?